Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Medicago Opens Vaccine Research and Production Facility
Medicago opened its $32 million Vaccine Research and Production Facility in September of 2011. Located in Research Triangle Park, the 97,000-sf project will support commercial grade production of influenza vaccines using VLP (virus-like particle) plant-based manufacturing technology. The general contractor, KBR Building Group, was awarded a $19 million contract to build the facility in November of 2010. The plant can produce 10 million doses per month and can increase production within three months to respond to an influenza pandemic.
NanoViricides Expands in West Haven
NanoViricides is expanding in West Haven, Conn., with the acquisition of an 18,000-sf facility. The building will house laboratories and a cGMP pilot plant for production of nanoviricide pharmaceutical candidates for clinical trials. NanoViricides is engaged in creating anti-viral drugs for H1N1, H5N1, seasonal influenza, hepatitis, rabies, Dengue fever, and Ebola.
Analog Devices Expands in Ireland
Analog Devices will construct a $68.3 million research and development facility in Raheen, Ireland. Built adjacent to Analog's existing manufacturing center, the two-story, 140,000-sf facility will house engineering labs, offices, and meeting rooms to accommodate 100 employees. Analog Devices is a semiconductor manufacturer based in Boston.
Bridgewater State University Opens Science and Mathematics Center
Bridgewater State University opened the first phase of the newly expanded and renovated Science and Mathematics Center in September of 2011. Designed by Payette, the five-story, 168,000-sf facility will provide space for the departments of biology, chemistry, earth science, geography, physics, math, and computer science. The project team includes R.G.
Memphis Bioworks Builds Commercialization Laboratory
Memphis Bioworks Foundation is planning to build the $15.2 million Memphis Specialized Laboratory. The 26,000-sf facility will help companies obtain U.S. FDA approval for products, enabling rapid commercialization of research discoveries. The facility was designed by Perkins+Will of Houston and Self+Tucker Architects of Memphis with Flintco as general contractor. The duration of construction is estimated to be 14 months plus two months for facility commissioning.